Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Business HAVN enters psilocybin mushroom supply agreement with Jamaican cannabis producer Green Stripe was one of the first cannabis companies to get established in Jamaica Natalia Buendia CalvilloJune 7, 2022
Business Optimi enters natural psilocybin supply agreement with Filament Health The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton Natalia Buendia CalvilloMay 31, 2022
Business Optimi Health enters psilocybin mushroom supply agreement with Halucenex Life Sciences The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies Natalia Buendia CalvilloMay 27, 2022
Business Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto Ryan GarnerApril 19, 2022
Medical and Pharmaceutical Psilocybin temporarily disrupts stages of the sleep cycle : study But whether or not the disruption helps with the substance's antidepressant properties still needs further research Natalia Buendia CalvilloApril 11, 2022
News Therapists’ personal experience important for patients undergoing psilocybin-assisted therapy: study Previous experience was rated more important than shared symptoms, gender or ethnicity Natalia Buendia CalvilloMarch 28, 2022
Psychedelics Psilocybin safer to take with psychiatric medications than MDMA, researchers say Mixing MDMA with heavier antidepressants can be fatal Natalia Buendia CalvilloMarch 10, 2022
News Only difference between LSD and synthetic psilocybin experience is duration, researchers say But there are some physiological differences between the two Natalia Buendia CalvilloMarch 2, 2022
News Psilocybin therapy for major depression can relieve symptoms for a year: study The long-term benefits contrast with the more temporary effects of conventional antidepressants Natalia Buendia CalvilloFebruary 18, 2022